article · Journal of Medical Entomology
Comprehensive risk assessment for vector-borne disease requires effective monitoring of various vector groups. However, this depends on the traps' ability to capture multiple vector families. This study compares 3 commercially available traps, BG-Sentinel 2, BG-Trap Station as a combination of a BG-Pro and Gravid trap, and the Encephalitis Virus Surveillance trap, with the VectorCube, a newly developed prototype. Multiple openings enable multidirectional vector capture, and color cues can be easily attached and changed. All traps were tested under a uniform, carbon dioxide flow rate at 10 sampling sites (6 in Germany and 4 in Gabon) using a 4 × 4 Latin square design. Each site completed at least 1 full Latin square rotation, resulting in 48 trap comparison days. A total of 3,477 blood-seeking insects from 6 families were captured: 2,797 Culicidae, 324 Simuliidae, 268 Ceratopogonidae, 76 Muscidae, 8 Glossinidae, and 4 Psychodidae. Most Culicidae were collected with the BG-Sentinel 2 followed by the VectorCube. The VectorCube captured the majority of Simuliidae, Muscidae, and Glossinidae observed in this study, while Psychodidae were exclusively collected with BG-Sentinel 2 and BG-Trap Station in Gabon. Mean family richness per trapping session was highest in the VectorCube, followed by BG-Sentinel 2, BG-Trap Station, and Encephalitis Virus Surveillance trap. Overall, the VectorCube and BG-Sentinel 2 demonstrated the highest performance in vector abundance and diversity, driven primarily by high Culicidae catches, whereas captures of non-mosquito hematophagous Diptera occured at lower frequencies and were more site-dependent, including sporadic captures of larger-bodied vectors such as Muscidae and Glossinidae.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1093/jme/tjag042
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.